Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longevity Health Holdings, Inc.CTCX · Entity 8659 | Director | October 11, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longevity Health Holdings, Inc.
Report date October 11, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-10-11 | Direct | 76,878 |
Reported balance
After 2024-10-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-10-11 · Grant · Acquired 76,878 · Balance 76,878 F2: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.11 · Expires 2031-09-23 | Direct | 76,878 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 76,878 F2: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Commmon StockSEC Table I · non-derivative | IndirectHarbor Light Capital Partners | 1,358,019 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,358,019 F1: Carmell Series of Harbor Light Direct Investment, LLC is the record holder of 1,248,114 shares and Harbor Light Direct Investment, LP is the record holder of 109,905 shares. The Reporting Person is the General Partner of Harbor Light Capital Partners, the investment manager to these entities, and may be deemed the beneficial owner of such shares. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. |
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Carmell Series of Harbor Light Direct Investment, LLC is the record holder of 1,248,114 shares and Harbor Light Direct Investment, LP is the record holder of 109,905 shares. The Reporting Person is the General Partner of Harbor Light Capital Partners, the investment manager to these entities, and may be deemed the beneficial owner of such shares. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest.
F2: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2024 Filed Nov 8, 2024 17:00 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 76,878 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-124217 · ownership.xml · derivative · entry 3 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,878 Underlying: Common Stock · 76,878 shares Expires 2034-10-11 F2 · derivative.exercise_date: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 5,000 | $0.47 | $2,336.00 |
DisclosureSEC source: 0000950170-24-106857 · ownership.xml · nonDerivative · entry 1 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $0.458 to $0.480, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 17:57 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 3,600 | $0.89 | $3,218.40 |
DisclosureSEC source: 0000950170-24-099586 · ownership.xml · nonDerivative · entry 1 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $0.889 to $0.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 08:21 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,000 | $2.20 | $4,409.20 |
DisclosureSEC source: 0000950170-24-073349 · ownership.xml · nonDerivative · entry 1 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,400 F1 · balance_after: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.1835 to $2.2257, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 Read SEC document |
| December 13, 2023 Filed Dec 13, 2023 21:53 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,400 | $3.47 | $8,330.40 |
DisclosureSEC source: 0000950170-23-070174 · ownership.xml · nonDerivative · entry 2 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,400 F1 · balance_after: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.46 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:53 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,000 | $3.50 | $7,000.00 |
DisclosureSEC source: 0000950170-23-070174 · ownership.xml · nonDerivative · entry 1 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock Warrants · Derivative | 69 | Not disclosed Strike: $6.71 | Not disclosed |
DisclosureSEC source: 0001062993-23-015056 · form4.xml · derivative · entry 5 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Harbor Light Direct Investment, LP Disclosed balance after: 69 Underlying: Common Stock · 69 shares Expires 2032-09-30 F5 · kind: As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation. F5 · price: As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation. F4 · derivative.exercise_date: These warrants are currently exercisable. F1 · ownership.nature: Mr. Upton is General Partner at Harbor Light Capital Partners, which is affiliated with the entities listed above. By virtue of this relationship, Mr. Upton may be deemed to share beneficial ownership of the securities held of record by the entities listed above. Mr. Upton disclaims any such beneficial ownership except to the extent of his pecuniary interest. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock Warrants · Derivative | 895 | Not disclosed Strike: $6.71 | Not disclosed |
DisclosureSEC source: 0001062993-23-015056 · form4.xml · derivative · entry 4 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Carmell Series of Harbor Light Direct Investment, LLC Disclosed balance after: 895 Underlying: Common Stock · 895 shares Expires 2024-09-30 F5 · kind: As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation. F5 · price: As part of the Business Combination, existing warrants to purchase common stock of Legacy Carmell were exchanged for 0.06154 warrants to purchase shares of common stock of Carmell Therapeutics Corporation. F4 · derivative.exercise_date: These warrants are currently exercisable. F1 · ownership.nature: Mr. Upton is General Partner at Harbor Light Capital Partners, which is affiliated with the entities listed above. By virtue of this relationship, Mr. Upton may be deemed to share beneficial ownership of the securities held of record by the entities listed above. Mr. Upton disclaims any such beneficial ownership except to the extent of his pecuniary interest. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:36 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 76,878 | Not disclosed Strike: $2.11 | Not disclosed |
DisclosureSEC source: 0001062993-23-015056 · form4.xml · derivative · entry 3 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,878 Underlying: Common Stock · 76,878 shares Expires 2031-09-23 F3 · price: On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation. F2 · derivative.exercise_date: Options to purchase 76,878 shares of common stock of Legacy Carmell (as defined below) granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| September 23, 2021 Filed Dec 13, 2023 21:53 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-070174 · ownership.xml · nonDerivative · entry 3 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,845 F2 · balance_after: The shares beneficially owned by the Reporting Person include 44,845 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023. Read SEC document |
| September 23, 2021 Filed Jun 14, 2024 08:21 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-073349 · ownership.xml · nonDerivative · entry 2 Upton Richard A · CIK 0001375726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,445 F2 · balance_after: The shares beneficially owned by the Reporting Person include 54,455 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of June 12, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.